T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients
Clinical trial NCT05953168 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05953168
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-08-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.